Characterization of the native and fibrillar conformation of the human Nα-acetyltransferase ARD1

Protein Science

Volumn 15, Issue 8, 2006, Pages 1968-1976

  Sánchez Puig, Nuria ^a,b,c   Fersht, Alan R ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Amyloid fibers; ARD1; Protofilaments

Indexed keywords

ACYLTRANSFERASE; ARREST DEFECTIVE PROTEIN 1; CONGO RED; GLOBULAR PROTEIN; N ACETYLTRANSFERASE PROTEIN 1; THIOFLAVINE; UNCLASSIFIED DRUG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CIRCULAR DICHROISM; ELECTRON MICROSCOPY; FLUORESCENCE SPECTROSCOPY; GEL PERMEATION CHROMATOGRAPHY; HUMAN; PH; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN DENATURATION; PROTEIN FOLDING; PROTEIN STABILITY; PROTEIN STRUCTURE; STAINING; TEMPERATURE;

ACETYLTRANSFERASES; AMINO ACID SEQUENCE; CHROMATOGRAPHY, GEL; CIRCULAR DICHROISM; ENZYME STABILITY; HEAT; HUMANS; MICROSCOPY, ELECTRON; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; PROTEIN DENATURATION; PROTEIN FOLDING; SPECTROMETRY, FLUORESCENCE; UREA;

EUKARYOTA;

EID: 33746491112     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1110/ps.062264006     Document Type: Article

References (44)

1. Arnesen, T., Anderson, D., Baldersheim, C., Lanotte, M., Varhaug, J.E., and Lillehaug, J.R. 2005a. Identification and characterization of the human ARD1-NATH protein acetyltransferase complex. Biochem. J. 386: 433-443.
2. Arnesen, T., Gromyko, D., Horvli, O., Fluge, O., Lillehaug, J., and Varhaug, J.E. 2005b. Expressi on of N-acetyl transferase human and human arrest defective 1 proteins in thyroid neoplasms. Thyroid 15: 1131-1136.
3. Arnesen, T., Kong, X., Evjenth, R., Gromyko, D., Varhaug, J.E., Lin, Z., Sang, N., Caro, J., and Lillehaug, J.R. 2005c. Interaction between HIF-1α (ODD) and hARD1 does not induce acetylation and destabilization of HIF-1α. FEBS Lett. 579: 6428-6432.
4. Arnold, R.J., Polevoda, B., Reilly, J.P., and Sherman, F. 1999. The action of N-terminal acetyltransferases on yeast ribosomal proteins. J. Biol. Chem. 274: 37035-37040.
5. Asaumi, M., Iijima, K., Sumioka, A., Iijima-Ando, K., Kirino, Y., Nakaya, T., and Suzuki, T. 2005. Interaction of N-terminal acetyltransferase with the cytoplasmic domain of β-amyloid precursor protein and its effect on Aβ secretion. J. Biochem. 137: 147-155.
6. Balguerie, A., Dos Reis, S., Ritter, C., Chaignepain, S., Coulary-Salin, B., Forge, V., Bathany, K., Lascu, I., Schmitter, J.M., Riek, R., et al. 2003. Domain organization and structure-function relationship of the HET-s prion protein of Podospora anserina. EMBO J. 22: 2071-2081.
7. Bilton, R., Mazure, N., Trottier, E., Hattab, M., Dery, M.A., Richard, D.E., Pouyssegur, J., and Brahimi-Horn, M.C. 2005. Arrest-defective-1 protein, an acetyltransferase, does not alter stability of hypoxia-inducible factor (HIF)-1α and is not induced by hypoxia or HIF. J. Biol. Chem. 280: 31132-31140.
8. Booth, D.R., Sunde, M., Bellotti, V., Robinson, C.V., Hutchinson, W.L., Fraser, P.E., Hawkins, P.N., Dobson, C.M., Radford, S.E., Blake, C.C., et al. 1997. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature 385: 787-793.
9. Bousset, L., Redeker, V., Decottignies, P., Dubois, S., Le Marechal, P., and Melki, R. 2004. Structural characterization of the fibrillar form of the yeast Saccharomyces cerevisiae prion Ure2p. Biochemistry 43: 5022-5032.
10. α-acetyl transferase families. Trends Biochem. Sci. 23: 263-267.
11. Bullock, A.N., Henckel, J., DeDecker, B.S., Johnson, C.M., Nikolova, P.V., Proctor, M.R., Lane, D.P., and Fersht, A.R. 1997. Thermodynamic stability of wild-type and mutant p53 core domain. Proc. Natl. Acad. Sci. 94: 14338-14342.
12. Caughey, B. and Lansbury, P.T. 2003. Protofibrils, pores, fibrils, and neurodegeneration: Separating the responsible protein aggregates from the innocent bystanders. Annu. Rev. Neurosci. 26: 267-298.
13. Cuff, J.A. and Barton, G.J. 1999. Evaluation and improvement of multiple sequence methods for protein secondary structure prediction. Proteins 34: 508-519.
14. Dobson, C.M. 1999. Protein misfolding, evolution and disease. Trends Biochem. Sci. 24: 329-332.
15. _. 2001. The structural basis of protein folding and its links with human disease. Philos. Trans. R. Soc. Lond. B Biol. Sci. 356: 133-145.
16. _. 2004. Principles of protein folding, misfolding and aggregation. Semin. Cell Dev. Biol. 15: 3-16.
17. Dunker, A.K., Lawson, J.D., Brown, C.J., Williams, R.M., Romero, P., Oh, J.S., Oldfield, C.J., Campen, A.M., Ratliff, C.M., Hipps, K.W., et al. 2001. Intrinsically disordered protein. J. Mol. Graph. Model. 19: 26-59.
18. Fersht, A. 1998. Protein stability. In Structure and mechanism in protein science: A guide to enzyme catalysis and protein folding, 1st ed., pp. 508-539. W.H. Freeman and Company, New York.
19. Fisher, T.S., Etages, S.D., Hayes, L., Crimin, K., and Li, B. 2005. Analysis of ARD1 function in hypoxia response using retroviral RNA interference. J. Biol. Chem. 280: 17749-17757.
20. Guijarro, J.I., Sunde, M., Jones, J.A., Campbell, I.D., and Dobson, C.M. 1998. Amyloid fibril formation by an SH3 domain. Proc. Natl. Acad. Sci. 95: 4224-4228.
21. Ivanova, M.I., Gingery, M., Whitson, L.J., and Eisenberg, D. 2003. Role of the C-terminal 28 residues of β2-microglobulin in amyloid fibril formation. Biochemistry 42: 13536-13540.
22. Jeong, J.W., Bae, M.K., Ahn, M.Y., Kim, S.H., Sohn, T.K., Bae, M.H., Yoo, M.A., Song, E.J., Lee, K.J., and Kim, K.W. 2002. Regulation and destabilization of HIF-1α by ARD1-mediated acetylation. Cell 111: 709-720.
23. Kim, S.H., Park, J.A., Kim, J.H., Lee, J.W., Seo, J.H., Jung, B.K., Chun, K.H., Jeong, J.W., Bae, M.K., and Kim, K.W. 2006. Characterization of ARD1 variants in mammalian cells. Biochem. Biophys. Res. Commun. 340: 422-427.
24. Klunk, W.E., Pettegrew, J.W., and Abraham, D.J. 1989. Quantitative evaluation of congo red binding to amyloid-like proteins with a β-pleated sheet conformation. J. Histochem. Cytochem. 37: 1273-1281.
25. Klunk, W.E., Jacob, R.F., and Mason, R.P. 1999. Quantifying amyloid by Congo red spectral shift assay. Methods Enzymol. 309: 285-305.
26. Lai, Z., Colon, W., and Kelly, J.W. 1996. The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. Biochemistry 35: 6470-6482.
27. Lashuel, H.A., Wurth, C., Woo, L., and Kelly, J.W. 1999. The most pathogenic transthyretin variant, L55P, forms amyloid fibrils under acidic conditions and protofilaments under physiological conditions. Biochemistry 38: 13560-13573.
28. LeVine III, H. 1993. Thioflavine T interaction with synthetic Alzheimer's disease β-amyloid peptides: Detection of amyloid aggregation in solution. Protein Sci. 2: 404-410.
29. LeVine III, H. 1999. Quantification of β-sheet amyloid fibril structures with thioflavin T. Methods Enzymol. 309: 274-284.
30. Li, H.T., Du, H.N., Tang, L., Hu, J., and Hu, H.Y. 2002. Structural transformation and aggregation of human α-synuclein in trifluoroethanol: Non-amyloid component sequence is essential and β-sheet formation is pre-requisite to aggregation. Biopolymers 64: 221-226.
31. McParland, V.J., Kad, N.M., Kalverda, A.P., Brown, A., Kirwin-Jones, P., Hunter, M.G., Sunde, M., and Radford, S.E. 2000. Partially unfolded states of β(2)-microglobulin and amyloid formation in vitro. Biochemistry 39: 8735-8746.
32. Miake, H., Mizusawa, H., Iwatsubo, T., and Hasegawa, M. 2002. Biochemical characterization of the core structure of α-synuclein filaments. J. Biol. Chem. 277: 19213-19219.
33. Miroux, B. and Walker, J.E. 1996. Over-production of proteins in Escherichia coli: Mutant hosts that allow synthesis of some membrane proteins and globular proteins at high levels.. J. Mol. Biol. 260: 289-298.
34. Murray-Rust, T.A., Oldham, N.J., Hewitson, K.S., and Schofield, C.J. 2006. Purified recombinant hARD1 does not catalyse acetylation of Lys532 of HIF-1α fragments in vitro. FEBS Lett. 580: 1911-1918.
35. Myers, J.K., Pace, C.N., and Scholtz, J.M. 1995. Denaturant m values and heat capacity changes: Relation to changes in accessible surface areas of protein unfolding. Protein Sci. 4: 2138-2148.
36. Park, E.C. and Szostak, J.W. 1992. ARD1 and NAT1 proteins form a complex that has N-terminal acetyltransferase activity. EMBO J. 11: 2087-2093.
37. Perrett, S., Freeman, S.J., Butler, P.J., and Fersht, A.R. 1999. Equilibrium folding properties of the yeast prion protein determinant Ure2. J. Mol. Biol. 290: 331-345.
38. Polevoda, B. and Sherman, F. 2003. Composition and function of the eukaryotic N-terminal acetyltransferase subunits. Biochem. Biophys. Res. Commun. 308: 1-11.
39. Romero, P., Obradovic, Z., Li, X., Garner, E.C., Brown, C.J., and Dunker, A.K. 2001. Sequence complexity of disordered protein. Proteins 42: 38-48.
40. Sánchez-Puig, N., Veprintsev, D.B., and Fersht, A.R. 2005. Binding of natively unfolded HIF-1α ODD domain to p53. Mol. Cell 17: 11-21.
41. Sugiura, N., Adams, S.M., and Corriveau, R.A. 2003. An evolutionarily conserved N-terminal acetyltransferase complex associated with neuronal development. J. Biol. Chem. 278: 40113-40120.
42. Sunde, M. and Blake, C. 1997. The structure of amyloid fibrils by electron microscopy and X-ray diffraction. Adv. Protein Chem. 50: 123-159.
43. Thual, C., Bousset, L., Komar, A.A., Walter, S., Buchner, J., Cullin, C., and Melki, R. 2001. Stability, folding, dimerization, and assembly properties of the yeast prion Ure2p. Biochemistry 40: 1764-1773.
44. Whiteway, M. and Szostak, J.W. 1985. The ARD1 gene of yeast functions in the switch between the mitotic cell cycle and alternative developmental pathways. Cell 43: 483-492.